<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00730808</url>
  </required_header>
  <id_info>
    <org_study_id>N-POB-04-NL</org_study_id>
    <nct_id>NCT00730808</nct_id>
  </id_info>
  <brief_title>Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before Surgery</brief_title>
  <official_title>Efficacy and Tolerability of a Preoperative Oral Nutritional Supplement (PreOP Booster) vs. Placebo in Surgical Patients (Pilot Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fresenius Kabi</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fresenius Kabi</source>
  <brief_summary>
    <textblock>
      The aim of this pilot study is to investigate effectiveness, tolerability and safety of an
      oral nutritional supplement (PreOP Booster), given to rectal tumour patients prior to low
      anterior resection.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">November 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immunoinflammatory parameters</measure>
    <time_frame>on day -2, -1, 1, 2, 3, 5, and 7</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Antioxidant / oxidant parameters</measure>
    <time_frame>on day -2, 1, 3, 5, and 7</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ischemia / reperfusion injury parameters</measure>
    <time_frame>on day -2, 1, 3, 5, and 7</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pre-and postoperative discomfort (well-being)</measure>
    <time_frame>on day -1, and 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hand grip strength</measure>
    <time_frame>on day -2, 1, 2, 3, 5, and 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GI tolerance</measure>
    <time_frame>on day -1, 0, 1, 2, and 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety</measure>
    <time_frame>on day -1, 0, 1, 2, 3, 5, and 7</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Rectal Tumors</condition>
  <arm_group>
    <arm_group_label>Test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Oral nutritional supplement: assignment according to consecutive random numbers.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Assignment according to consecutive random numbers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PreOP Booster (food for special medical purposes)</intervention_name>
    <description>3x1 dosage is given prior to surgery: 2x1 the day prior to surgery; 1x1 3-4h prior to initiation of anaesthesia;</description>
    <arm_group_label>Test</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  rectal tumour with indication for elective low anterior resection (open surgery, not
             laparoscopic surgery) or abdominoperineal resection (APR)

          -  preoperative radiotherapy (5x5 Gy) or chemoradiation

          -  loop ileostoma or colostoma;

        Exclusion Criteria:

          -  severe malnutrition

          -  severe renal insufficiency

          -  diabetes mellitus I or II

          -  concomitant thyroid medication

          -  corticosteroids

          -  diuretic medication and antihypertensive medication

          -  known or suspected allergy to any component of the investigational product(s)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul A.M. van Leeuwen, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Amsterdam; The Netherlands</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical Center Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2008</study_first_submitted>
  <study_first_submitted_qc>August 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 8, 2008</study_first_posted>
  <last_update_submitted>May 18, 2010</last_update_submitted>
  <last_update_submitted_qc>May 18, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr. Steffen Benzing</name_title>
    <organization>Kabi Innovation Centre, Fresenius Kabi Deutschland GmbH</organization>
  </responsible_party>
  <keyword>Enteral nutritional regimen prior to surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

